RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Safety and efficacy of tocilizumab 4 or 8 mg/kg in hospitalized patients with moderate to severe coronavirus disease 2019 pneumonia: a randomized clinical trial

Safety and efficacy of tocilizumab 4 or 8 mg/kg in hospitalized patients with moderate to severe coronavirus disease 2019 pneumonia: a randomized clinical trial

Add to Collection
RCTs PN Kumar, J Hernández-Sánchez… - Open Forum …, 2022 - academic.oup.com

Chapter : Section15
Journal Year : 2022
Cited by : 13

… Severe COVID-19 pneumonia was defined as patients having blood oxygen saturation of ≤… with moderate pneumonia did not meet the oxygen requirements of severe pneumonia but …..... Read More

Keywords : ['severe coronavirus disease pneumonia', 'randomized clinical trial', 'hospitalize patient', 'tocilizumab', 'safety', 'moderate', 'mgkg', 'efficacy']
PubMed Link : https://academic.oup.com/ofid/article-abstract/9/1/ofab608/6449318
Google Scholar Link : https://scholar.google.com/scholar?cites=16649362994755812795&as_sdt=5,41&sciodt=0,41&hl=en&num=20